With Omar Hahad & Andreas Daiber, University Medical Center of the Johannes Gutenberg University Mainz, Mainz - Germany Link to paper Link to editorial

With Perry Elliott, University College London, London - United Kingdom of Great Britain & Northern Ireland & Athanasios Bakalakos, Barts Heart Centre, London - United Kingdom of Great Britain & Northern Ireland. Link to paper Link to editorial

Discussions on using Post-Ablation Cardiac Magnetic Resonance to evaluate ablation lesions in ventricular tachycardia, advancements in CMR for predicting recurrence, analyzing factors influencing low VT recurrence rate, exploring precision care in ablation, and novel ablation technologies for improving outcomes.

With Dominik Linz & Sevasti-Maria Chaldoupi, Maastricht University Medical Centre, Maastricht - Netherlands. Link to editorial Link to paper  

Swiss researchers Christoph Grani & Katja Odening discuss the assessment of risk stratification in hypertrophic cardiomyopathy (HCM) and the influence of genetics. They explore the role of genetic testing and late gadolinium enhancement (LGE) in diagnosing and visualizing fibrosis in HCM. The podcast also explores different approaches to quantifying LGE, the potential of AI-based segmentation, and the use of artificial intelligence for risk stratification and better patient outcomes.

With Trudy Pang & Richard Verrier, Beth Israel Deaconess Medical Center, Boston - USA. Link to paper Link to editorial

With Paul Leeson & Winok Lapidaire, University of Oxford - UK Link to editorial Link to paper

With Johann Bauersachs & Samira Soltani, Hannover Medical School, Hannover - Germany. Link to paper Link to editorial

With Gregg Pressman & Christian Witzke-Sanz, Thomas Jefferson University, Philadelphia - USA Link to paper Link editorial

With Luc Pierard, University of Liège, Liège - Belgium & Bernard Cosyns, University of Brussels, Brussels - Belgium Link to editorial Link to paper